Supplementary Data from Fructose Metabolism in Tumor Endothelial Cells Promotes Angiogenesis by Activating AMPK Signaling and Mitochondrial Respiration

Jian‐Hong Fang,Jieying Chen,Jia-Lin Zheng,Hui-Xian Zeng,Jun-Guang Chen,Chen-Hui Wu,Jia-Li Cai,Zhi-Yong Wang,Shi‐Mei Zhuang

DOI: https://doi.org/10.1158/0008-5472.22632940

2023-01-01

Abstract:This PDF file includes:Supplementary Figures S1 to S11Supplementary Table S1

What problem does this paper attempt to address?

Fructose metabolism in tumor endothelial cells promotes angiogenesis by activating AMPK signaling and mitochondrial respiration.

Jun-Guang Chen,Zhi-Yong Wang,Hui-Xian Zeng,Jiekun Chen,Shi-Mei Zhuang,Jian‐Hong Fang,Chen-Hui Wu,Jia-Lin Zheng,Jia-Li Cai

DOI: https://doi.org/10.1158/0008-5472.CAN-22-1844

IF: 11.2

2023-01-30

Cancer Research

Abstract:Angiogenesis is vital for tumor growth and metastasis. Emerging evidence suggests that metabolic reprogramming in endothelial cells (ECs) may affect angiogenesis. Here, we showed that multiple regulators in the fructose metabolism pathway, especially fructose transporter SLC2A5 and fructose-metabolizing enzyme ketohexokinase (KHK), were upregulated in tumor endothelial cells from hepatocellular carcinoma (HCC). In mouse models with hepatoma xenografts or with Myc/sgp53-induced liver cancer, dietary fructose enhanced tumor angiogenesis, tumor growth, and metastasis, which could be attenuated by treatment with an inhibitor of SLC2A5. Furthermore, vessel growth was substantially increased in fructose-containing matrigel compared to PBS-matrigel. Inhibiting fructose metabolism in EC cells in vivo using EC-targeted nanoparticles loaded with siRNA against KHK significantly abolished fructose-induced tumor angiogenesis. Fructose treatment promoted the proliferation, migration and tube formation of ECs and stimulated mitochondrial respiration and ATP production. Elevated fructose metabolism activated AMPK to fuel mitochondrial respiration, resulting in enhanced EC migration. Fructose metabolism was increased under hypoxic conditions as a result of HIF1α-mediated upregulation of multiple genes in the fructose metabolism pathway. These findings highlight the significance of fructose metabolism in ECs for promoting tumor angiogenesis. Restricting fructose intake or targeting fructose metabolism is a potential strategy to reduce angiogenesis and suppress tumor growth.

Biology,Medicine
Fructose promotes angiogenesis by improving vascular endothelial cell function and upregulating VEGF expression in cancer cells

Yanfen Cui,Hui Liu,Zhaosong Wang,He Zhang,Jianfei Tian,Zhiyong Wang,Weijie Song,Hui Guo,Liming Liu,Ruinan Tian,Xiaoyan Zuo,Sixin Ren,Fei Zhang,Ruifang Niu

DOI: https://doi.org/10.1186/s13046-023-02765-3

2023-07-28

Abstract:Background: Fructose is a very common sugar found in natural foods, while current studies demonstrate that high fructose intake is significantly associated with increased risk of multiple cancers and more aggressive tumor behavior, but the relevant mechanisms are not fully understood. Methods: Tumor-grafting experiments and in vitro angiogenesis assays were conducted to detect the effect of fructose and the conditioned medium of fructose-cultured tumor cells on biological function of vascular endothelial cells (VECs) and angiogenesis. 448 colorectal cancer specimens were utilized to analyze the relationship between Glut5 expression levels in VECs and tumor cells and microvascular density (MVD). Results: We found that fructose can be metabolized by VECs and activate the Akt and Src signaling pathways, thereby enhancing the proliferation, migration, and tube-forming abilities of VECs and thereby promoting angiogenesis. Moreover, fructose can also improve the expression of vascular endothelial growth factor (VEGF) by upregulating the production of reactive oxygen species (ROS) in colorectal cancer cells, thus indirectly enhancing the biological function of VECs. Furthermore, this pro-angiogenic effect of fructose metabolism has also been well validated in clinical colorectal cancer tissues and mouse models. Fructose contributes to angiogenesis in mouse subcutaneous tumor grafts, and MVD is positively correlated with Glut5 expression levels of both endothelial cells and tumor cells of human colorectal cancer specimens. Conclusions: These findings establish the direct role and mechanism by which fructose promotes tumor progression through increased angiogenesis, and provide reliable evidence for a better understanding of tumor metabolic reprogramming.
Fig S1-S8 from Aberrant FGFR Tyrosine Kinase Signaling Enhances the Warburg Effect by Reprogramming LDH Isoform Expression and Activity in Prostate Cancer

Junchen Liu,Guo Chen,Zezhen Liu,Shaoyou Liu,Zhiduan Cai,Pan You,Yuepeng Ke,Li Lai,Yun Huang,Hongchang Gao,Liangcai Zhao,Helene Pelicano,Peng Huang,Wallace L. McKeehan,Chin-Lee Wu,Cong Wang,Weide Zhong,Fen Wang

DOI: https://doi.org/10.1158/0008-5472.22419839.v1

2023-01-01

Abstract:This file containing all the supplemental data supporting the statements indicated in the manuscripts.
Supplementary Data from ANGPTL4-Mediated Promotion of Glycolysis Facilitates the Colonization of Fusobacterium Nucleatum in Colorectal Cancer

Xin Zheng,Rui Liu,Chenchen Zhou,Haopeng Yu,Wanyi Luo,Jianhui Zhu,Jiaxin Liu,Zhe Zhang,Na Xie,Xian Peng,Xin Xu,Lei Cheng,Quan Yuan,Canhua Huang,Xuedong Zhou

DOI: https://doi.org/10.1158/0008-5472.22569169.v1

2023-01-01

Abstract:Supplementary Figure 1-8 (Fig. S1-8) and Supplementary Table 1 and 2 (Table. S1 and 2)
Non-dietary Fructose Metabolism Contributes to the Warburg effect in Cancers

B. Han,Lu Wang,Meilin Wei,C. Rajani,Runmin Wei,Jingye Wang,Hai-ning,Yang,M. Carbone,G. Xie,W. Jia

2020-01-01

Abstract:Fructose metabolism is increasingly recognized as a preferred energy source for cancer cell proliferation. However, dietary fructose rarely enters the bloodstream. Therefore, it remains unclear how cancer cells acquire a sufficient amount of fructose to supplement their energy needs. Here we report that the cancer cells can convert glucose into fructose through intraand extracellular polyol pathways. The fructose metabolism bypasses normal aerobic respiration’s self-control to supply excessive metabolites to glycolysis and causes the Warburg effect. Inhibition of fructose production drastically suppressed glycolysis and ATP production in cancers. Furthermore, we determined that a glucose transporter, SLC2A8/GLUT8, exports intracellular fructose to other cells in the tumor microenvironment. Taken together, our study identified overlooked fructose resources for cancer cells as an essential part of their metabolic reprogramming and caused the Warburg effect. Declaration of Interests The authors declare no competing interests. 1 Cancer Biology Program, University of Hawaii Cancer Center, Honolulu, HI, 96813, USA. 2 Human Metabolomics Institute, Inc., Shenzhen, Guangdong, 518109, China. 3 Shanghai Key Laboratory of Diabetes Mellitus and Center for Translational Medicine, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai, 200233, China. 4 School of Chinese Medicine, Hong Kong Baptist University, Kowloon Tong, Hong Kong. *Equal contributions. Correspondence: WJia@cc.hawaii.edu.
Supplementary Data from Hypoxia Promotes Breast Cancer Cell Growth by Activating a Glycogen Metabolic Program

Ke Tang,Liyan Zhu,Jie Chen,Dianheng Wang,Liping Zeng,Chen Chen,Liang Tang,Li Zhou,Keke Wei,Yabo Zhou,Jiadi Lv,Yuying Liu,Huafeng Zhang,Jingwei Ma,Bo Huang

DOI: https://doi.org/10.1158/0008-5472.22430538.v1

2023-01-01

Abstract:Figure S1-7, Table S1
Fructose Metabolism Contributes to the Warburg effect

Bing Han,Lu Wang,Jingyu Zhang,Meilin Wei,Cynthia Rajani,Runming Wei,Jingye Wang,Haining Yang,Michele Carbone,Guoxiang Xie,Wen Zhou,wei jia

DOI: https://doi.org/10.1101/2020.06.04.132902

2021-01-01

bioRxiv

Abstract:Fructose metabolism is increasingly recognized as a preferred energy source for cancer cell proliferation. However, it remains unclear why cancer cells favor fructose metabolism and how they acquire a sufficient amount of fructose. Here we report that cancer cells convert glucose into fructose through intra- and extracellular polyol pathways. The fructose metabolism bypasses normal aerobic respiration9s self-control to supply excessive metabolites to glycolysis and promotes the Warburg effect. Inhibition of fructose production drastically suppressed glycolysis and ATP production in cancer. Furthermore, we determined that a glucose transporter, SLC2A8/GLUT8, exports intracellular fructose to other cells in the tumor microenvironment. Taken together, our study suggests that the Warburg effect is achieved by means of fructose metabolism, instead of glucose metabolism alone.
Data from Fructose-Induced Mtorc1 Activation Promotes Pancreatic Cancer Progression Through Inhibition of Autophagy

Yanfen Cui,Jianfei Tian,Zhaosong Wang,Hui Guo,He Zhang,Zhiyong Wang,Hui Liu,Weijie Song,Liming Liu,Ruinan Tian,Xiaoyan Zuo,Sixin Ren,Ruifang Niu,Fei Zhang

DOI: https://doi.org/10.1158/0008-5472.c.6982743

2023-01-01

Abstract:AbstractExcessive fructose intake is associated with the occurrence, progression, and poor prognosis of various tumors. A better understanding of the mechanisms underlying the functions of fructose in cancer could facilitate the development of better treatment and prevention strategies. In this study, we investigated the functional association between fructose utilization and pancreatic ductal adenocarcinoma (PDAC) progression. Fructose could be taken up and metabolized by PDAC cells and provided an adaptive survival mechanism for PDAC cells under glucose-deficient conditions. GLUT5-mediated fructose metabolism maintained the survival, proliferation, and invasion capacities of PDAC cells in vivo and in vitro. Fructose metabolism not only provided ATP and biomass to PDAC cells but also conferred metabolic plasticity to the cells, making them more adaptable to the tumor microenvironment. Mechanistically, fructose activated the AMP-activated protein kinase (AMPK)–mTORC1 signaling pathway to inhibit glucose deficiency-induced autophagic cell death. Moreover, the fructose-specific transporter GLUT5 was highly expressed in PDAC tissues and was an independent marker of disease progression in patients with PDAC. These findings provide mechanistic insights into the role of fructose in promoting PDAC progression and offer potential strategies for targeting metabolism to treat PDAC.Significance:Fructose activates AMPK–mTORC1 signaling to inhibit autophagy-mediated cell death in pancreatic cancer cells caused by glucose deficiency, facilitating metabolic adaptation to the tumor microenvironment and supporting tumor growth.
Fructose fuels tumor growth through the polyol pathway and GLUT 8 transporter

Bing Han,Lu Wang,Meilin Wei,Cynthia Rajani,Haining Yang,Guoxiang Xie,Wei Jia

DOI: https://doi.org/10.1101/2020.06.04.132902

2020-01-01

Abstract:Fructose metabolism is increasingly recognized as a preferred energy source for cancer cell proliferation. However, dietary fructose rarely enters the bloodstream, and its fasting blood levels are much lower (~0.005 mM) than glucose (~5.5 mM) under normal physiological conditions. Therefore, it remains unclear where fructose is derived from and how cancer cells acquire a sufficient amount of fructose to supplement their energy needs. Here we report that the polyol pathway is active in cancer cells and is capable of converting up to 50% of glucose into fructose, resulting in enhanced glycolysis and ATP production. Inhibition of the polyol pathway severely decreased fructose production in cancer cells and suppressed their glycolysis, ATP production, and growth rate. Furthermore, we determined that the glucose transporter, SLC2A8/GLUT8, was a crucial transporter to export intracellular fructose outside cells. Taken together, our study identified an overlooked but critically essential fructose-producing pathway in cancer cells as an integral part of their metabolic reprogramming leading to enhanced glycolysis, cell proliferation, and malignancy.
AKR1B1 -dependent fructose metabolism enhances malignancy of cancer cells

Qing Zhao,Bing Han,Lu Wang,Jia Wu,Siliang Wang,Zhenxing Ren,Shouli Wang,Haining Yang,Michele Carbone,Changsheng Dong,Gerry Melino,Wen-Lian Chen,Wei Jia

DOI: https://doi.org/10.1038/s41418-024-01393-4

IF: 12.067

2024-10-16

Cell Death and Differentiation

Abstract:Fructose metabolism has emerged as a significant contributor to cancer cell proliferation, yet the underlying mechanisms and sources of fructose for cancer cells remain incompletely understood. In this study, we demonstrate that cancer cells can convert glucose into fructose through a process called the AKR1B1 -mediated polyol pathway. Inhibiting the endogenous production of fructose through AKR1B1 deletion dramatically suppressed glycolysis, resulting in reduced cancer cell migration, inhibited growth, and the induction of apoptosis and cell cycle arrest. Conversely, the acceleration of endogenous fructose through AKR1B1 overexpression has been shown to significantly enhance cancer cell proliferation and migration with increased S cell cycle progression. Our findings highlight the crucial role of endogenous fructose in cancer cell malignancy and support the need for further investigation into AKR1B1 as a potential cancer therapeutic target.

cell biology,biochemistry & molecular biology
Supplementary Methods, Tables, and Figures from Megakaryocytes Mediate Hyperglycemia-Induced Tumor Metastasis

Biying Wu,Ying Ye,Sisi Xie,Yintao Li,Xiaoting Sun,Mengyuan Lv,Ling Yang,Nan Cui,Qiying Chen,Lasse D. Jensen,Dongmei Cui,Guichun Huang,Ji Zuo,Shaochong Zhang,Wen Liu,Yunlong Yang

DOI: https://doi.org/10.1158/0008-5472.22429632

2023-01-01

Abstract:<p>Supplementary Methods, Tables, and Figures</p>
Additional File 4 of the EGFR-HSF1 Axis Accelerates the Tumorigenesis of Pancreatic Cancer

Weikun Qian,Ke Chen,Tao Qin,Ying Xiao,Jie Liu,Yangyang Yue,Cancan Zhou,Jiguang Ma,Wanxing Duan,Jing Liu,Liang Han,Lili Li,Xipeng Shen,Zheng Wu,Qingyong Ma,Zheng Wang

DOI: https://doi.org/10.6084/m9.figshare.13551078

2021-01-01

Abstract:Additional file 4: Table S3. Source files of bioinformatics analysis on EGFR pathway (GEO GSE98399 datasets).
Supplementary Figure 8 from Metastasis Suppressor KISS1 Seems to Reverse the Warburg Effect by Enhancing Mitochondrial Biogenesis

Wen Liu,Benjamin H. Beck,Kedar S. Vaidya,Kevin T. Nash,Kyle P. Feeley,Scott W. Ballinger,Keke M. Pounds,Warren L. Denning,Anne R. Diers,Aimee Landar,Animesh Dhar,Tomoo Iwakuma,Danny R. Welch

DOI: https://doi.org/10.1158/0008-5472.22400874.v1

2023-01-01

Abstract:PDF file - 2389K, Supplemental Figure 8. C8161.9 cell growth depends upon glucose, but not glutamine. C8161.9Vector (V), C8161.9KFMΔSS, C8161.9KFM and C8161.9KFM/shPGC1α (KFM shP) cells were cultured in 0.1% fetal bovine serum-containing DMEM in the presence (+) or absence (-) of glucose or L-glutamine for 10 days. Representative images of the cell cultures are shown.
Supplementary Figures from AMPK Alpha-1 Intrinsically Regulates the Function and Differentiation of Tumor Myeloid-Derived Suppressor Cells

Jimena Trillo-Tinoco,Rosa A. Sierra,Eslam Mohamed,Yu Cao,Álvaro de Mingo-Pulido,Danielle L. Gilvary,Carmen M. Anadon,Tara Lee Costich,Sheng Wei,Elsa R. Flores,Brian Ruffell,José R. Conejo-Garcia,Paulo C. Rodriguez

DOI: https://doi.org/10.1158/0008-5472.22421976

2023-01-01

Abstract:This file contains the Supplementary Figures 1-5. Supplementary Figure 1. Phospho-AMPKα1 levels increase in tumor-MDSC. Supplementary Figure 2. Tumor cell-derived GM-CSF triggers Ampkα expression in MDSC through Stat-5 activation. Supplementary Figure 3. MDSC in human myeloid progenitors treated with GM-CSF plus IL-6 for 7 days. Supplementary Figure 4. Extended survival of Prkaa1-null mice bearing ovarian tumors. Supplementary Figure 5. Effects of Prkaa1KO PMN-MDSC in tumor growth.
Dietary fructose enhances tumour growth indirectly via interorgan lipid transfer

Ronald Fowle-Grider,Joe L. Rowles,Isabel Shen,Yahui Wang,Michaela Schwaiger-Haber,Alden J. Dunham,Kay Jayachandran,Matthew Inkman,Michael Zahner,Fuad J. Naser,Madelyn M. Jackstadt,Jonathan L. Spalding,Sarah Chiang,Kyle S. McCommis,Roland E. Dolle,Eva T. Kramer,Sarah M. Zimmerman,George P. Souroullas,Brian N. Finck,Leah P. Shriver,Charles K. Kaufman,Julie K. Schwarz,Jin Zhang,Gary J. Patti

DOI: https://doi.org/10.1038/s41586-024-08258-3

IF: 64.8

2024-12-05

Nature

Abstract:Fructose consumption has increased considerably over the past five decades, largely due to the widespread use of high-fructose corn syrup as a sweetener 1 . It has been proposed that fructose promotes the growth of some tumours directly by serving as a fuel 2,3 . Here we show that fructose supplementation enhances tumour growth in animal models of melanoma, breast cancer and cervical cancer without causing weight gain or insulin resistance. The cancer cells themselves were unable to use fructose readily as a nutrient because they did not express ketohexokinase-C (KHK-C). Primary hepatocytes did express KHK-C, resulting in fructolysis and the excretion of a variety of lipid species, including lysophosphatidylcholines (LPCs). In co-culture experiments, hepatocyte-derived LPCs were consumed by cancer cells and used to generate phosphatidylcholines, the major phospholipid of cell membranes. In vivo, supplementation with high-fructose corn syrup increased several LPC species by more than sevenfold in the serum. Administration of LPCs to mice was sufficient to increase tumour growth. Pharmacological inhibition of ketohexokinase had no direct effect on cancer cells, but it decreased circulating LPC levels and prevented fructose-mediated tumour growth in vivo. These findings reveal that fructose supplementation increases circulating nutrients such as LPCs, which can enhance tumour growth through a cell non-autonomous mechanism.

multidisciplinary sciences
Supplementary Figure 7 from Metastasis Suppressor KISS1 Seems to Reverse the Warburg Effect by Enhancing Mitochondrial Biogenesis

Wen Liu,Benjamin H. Beck,Kedar S. Vaidya,Kevin T. Nash,Kyle P. Feeley,Scott W. Ballinger,Keke M. Pounds,Warren L. Denning,Anne R. Diers,Aimee Landar,Animesh Dhar,Tomoo Iwakuma,Danny R. Welch

DOI: https://doi.org/10.1158/0008-5472.22400877

2023-01-01

Abstract:PDF file - 1105K, Supplemental Figure 7. KISS1 inhibits glucose uptake and activation of AMPK. A, Glucose uptake by C8161.9Vector (Vec), C8161.9KFMΔSS, C8161.9KFM and C8161.9KFM/shPGC1α cells was measured using 2-deoxyglucose uptake and normalized to total protein. B, C8161.9Vector, C8161.9KFM and C8161.9KFMdeltaSS cells were treated with AICAR followed by Western blot with antibodies for AMPK, phospho-AMPK (Thr172), mTOR , phospho-mTOR (Ser2448), KISS1 and GAPDH.
Supplementary Figure from IFNα Potentiates Anti–PD-1 Efficacy by Remodeling Glucose Metabolism in the Hepatocellular Carcinoma Microenvironment

Bo Hu,Mincheng Yu,Xiaolu Ma,Jialei Sun,Chenglong Liu,Chunyan Wang,Suiyi Wu,Peiyao Fu,Zhen Yang,Yungang He,Yuanyuan Zhu,Cheng Huang,Xinrong Yang,Yinghong Shi,Shuangjian Qiu,Huichuan Sun,Andrew X. Zhu,Jian Zhou,Yang Xu,Di Zhu,Jia Fan

DOI: https://doi.org/10.1158/2159-8290.cd-21-1022

IF: 28.2

2022-01-01

Cancer Discovery

Abstract:Supplementary Figure from IFNα Potentiates Anti–PD-1 Efficacy by Remodeling Glucose Metabolism in the Hepatocellular Carcinoma Microenvironment
Supplementary Data from Targeting Purinergic Receptor P2Y2 Prevents the Growth of Pancreatic Ductal Adenocarcinoma by Inhibiting Cancer Cell Glycolysis

Li-Peng Hu,Xiao-Xin Zhang,Shu-Heng Jiang,Ling-Ye Tao,Qing Li,Li-Li Zhu,Ming-Wei Yang,Yan-Miao Huo,Yong-Sheng Jiang,Guang-Ang Tian,Xiao-Yan Cao,Yan-Li Zhang,Qin Yang,Xiao-Mei Yang,Ya-Hui Wang,Jun Li,Gary Guishan Xiao,Yong-Wei Sun,Zhi-Gang Zhang

DOI: https://doi.org/10.1158/1078-0432.22467476

2023-01-01

Abstract:Supplymentary data figure 1-8 and table 1-2
Supplementary Data from Mitochondrial Micropeptide STMP1 Enhances Mitochondrial Fission to Promote Tumor Metastasis

Chen Xie,Feng-Yi Wang,Ye Sang,Bin Chen,Jia-Hui Huang,Feng-Jun He,Hui Li,Ying Zhu,Xingguo Liu,Shi-Mei Zhuang,Jian-Hong Fang

DOI: https://doi.org/10.1158/0008-5472.22431981.v1

2023-01-01

Abstract:Supplementary Data from Mitochondrial Micropeptide STMP1 Enhances Mitochondrial Fission to Promote Tumor Metastasis
Supplementary Information from A Distinct Metabolic Signature of Human Colorectal Cancer with Prognostic Potential

Yunping Qiu,Guoxiang Cai,Bingsen Zhou,Dan Li,Aihua Zhao,Gary Xie,Houkai Li,Sanjun Cai,Dong Xie,Changzhi Huang,Weiting Ge,Zhanxiang Zhou,Lisa X. Xu,Jia Wang,Shusen Zheng,Yun Yen

DOI: https://doi.org/10.1158/1078-0432.22449236.v1

2023-01-01

Abstract:PDF file 119K, This file includes supplementary text and figure legends for supporting figures

Supplementary Data from Fructose Metabolism in Tumor Endothelial Cells Promotes Angiogenesis by Activating AMPK Signaling and Mitochondrial Respiration

Fructose metabolism in tumor endothelial cells promotes angiogenesis by activating AMPK signaling and mitochondrial respiration.

Fructose promotes angiogenesis by improving vascular endothelial cell function and upregulating VEGF expression in cancer cells

Fig S1-S8 from Aberrant FGFR Tyrosine Kinase Signaling Enhances the Warburg Effect by Reprogramming LDH Isoform Expression and Activity in Prostate Cancer

Supplementary Data from ANGPTL4-Mediated Promotion of Glycolysis Facilitates the Colonization of Fusobacterium Nucleatum in Colorectal Cancer

Non-dietary Fructose Metabolism Contributes to the Warburg effect in Cancers

Supplementary Data from Hypoxia Promotes Breast Cancer Cell Growth by Activating a Glycogen Metabolic Program

Fructose Metabolism Contributes to the Warburg effect

Data from Fructose-Induced Mtorc1 Activation Promotes Pancreatic Cancer Progression Through Inhibition of Autophagy

Fructose fuels tumor growth through the polyol pathway and GLUT 8 transporter

AKR1B1 -dependent fructose metabolism enhances malignancy of cancer cells

Supplementary Methods, Tables, and Figures from Megakaryocytes Mediate Hyperglycemia-Induced Tumor Metastasis

Additional File 4 of the EGFR-HSF1 Axis Accelerates the Tumorigenesis of Pancreatic Cancer

Supplementary Figure 8 from Metastasis Suppressor KISS1 Seems to Reverse the Warburg Effect by Enhancing Mitochondrial Biogenesis

Supplementary Figures from AMPK Alpha-1 Intrinsically Regulates the Function and Differentiation of Tumor Myeloid-Derived Suppressor Cells

Dietary fructose enhances tumour growth indirectly via interorgan lipid transfer

Supplementary Figure 7 from Metastasis Suppressor KISS1 Seems to Reverse the Warburg Effect by Enhancing Mitochondrial Biogenesis

Supplementary Figure from IFNα Potentiates Anti–PD-1 Efficacy by Remodeling Glucose Metabolism in the Hepatocellular Carcinoma Microenvironment

Supplementary Data from Targeting Purinergic Receptor P2Y2 Prevents the Growth of Pancreatic Ductal Adenocarcinoma by Inhibiting Cancer Cell Glycolysis

Supplementary Data from Mitochondrial Micropeptide STMP1 Enhances Mitochondrial Fission to Promote Tumor Metastasis

Supplementary Information from A Distinct Metabolic Signature of Human Colorectal Cancer with Prognostic Potential